CD24 and neoplasm: Cells co-expressing CD24 (epithelial marker) and CD44 (mesenchymal marker), CD24hi CD44hi, have been shown to correspond to a hybrid E/M phenotype [39] and possess higher tumour-initiation potential in vitro [39] and in vivo [40].